Genetic Signatures | GSS - Ebit

Stock Price
0.14
Daily Change
-0.01 -6.90%
Monthly
-43.75%
Yearly
-76.00%
Q1 Forecast
0.15

Genetic Signatures reported AUD-7.57M in EBIT for its fiscal semester ending in June of 2023.





Ebit Change Date
Avita Medical AUD -8.66M 1.61M Jun/2025
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge NZD -19.4M 2.91M Dec/2025
Paradigm Biopharmaceuticals AUD -19.93M 12.02M Jun/2023
Starpharma Holdings AUD -1.03M 6.36M Dec/2023
Telix Pharmaceuticals AUD 37.44M 16.38M Dec/2024